This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Neurodegeneration with brain iron accumulation syndromes (NBIAS) [14 genes]
NBIAS stands for ‘neurodegeneration with brain iron accumulation syndromes’ and covers a series of heterogeneous, often overlapping entities whose main characteristic is the accumulation of iron in the brain. This accumulation is predominantly observed at the level of the basal ganglia (mainly in the globus pallidus, substantia nigra, and adjacent areas) on brain MRI (T2, spin-echo, and gradient echo sequences). One of its most frequent forms is pantothenate kinase-associated neurodegeneration (PKAN, formerly known as Hallervorden-Spatz syndrome), which is generally recognized on MRI by the ‘eye of the tiger’ sign (a hypointense area with a hyperintense center in the globus pallidus).
The prevalence of these syndromes is estimated at around 1-3 every 1,000,000 individuals. They present clinically as neurodegenerative diseases with movement disorders and pyramidal, cerebellar, autonomic, and eventually cognitive and psychiatric signs.
Several causative genes have been identified for NBIAS. These genes are included in our panel, whose diagnostic yield allows explaining approximately 65% of cases (Schneider et al., 2016). In order of importance, it is worth highlighting the following genes: PANK2 (35-50%), PLA2G6 (20%), C19orf12 (6-10%), and WDR45 (1-2%) (Gregory and Hayflick, 2014).
Steps to follow
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Solicita información de
Neurodegeneration with brain iron accumulation syndromes (NBIAS)
Turnaround time (TAT): 6 weeks
Ref. S-202008625
- AP4S1
- ATP13A2
- C19orf12
- COASY
- CP
- DCAF17
- DDHD1
- FA2H
- FTL
- GTPBP2
- PANK2
- PLA2G6
- SCP2
- WDR45
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
- Gregory A, Hayflick S. Neurodegeneration with Brain Iron Accumulation Disorders Overview. 2013 Feb 28 [updated 2014 Apr 24]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.